Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Filters applied: . Clear all
Page 1
Postthrombotic syndrome and quality of life after deep vein thrombosis in patients treated with edoxaban versus warfarin.
Bistervels IM, Bavalia R, Beyer-Westendorf J, Ten Cate-Hoek AJ, Schellong SM, Kovacs MJ, Falvo N, Meijer K, Stephan D, Boersma WG, Ten Wolde M, Couturaud F, Verhamme P, Brisot D, Kahn SR, Ghanima W, Montaclair K, Hugman A, Carroll P, Pernod G, Sanchez O, Ferrari E, Roy PM, Sevestre-Pietri MA, Birocchi S, Wik HS, Hutten BA, Coppens M, Naue C, Grosso MA, Shi M, Lin Y, Quéré I, Middeldorp S; Hokusai PTS Investigators. Bistervels IM, et al. Among authors: quere i. Res Pract Thromb Haemost. 2022 Jul 1;6(5):e12748. doi: 10.1002/rth2.12748. eCollection 2022 Jul. Res Pract Thromb Haemost. 2022. PMID: 35992565 Free PMC article.
BACKGROUND: Postthrombotic syndrome (PTS) is a long-term complication after deep vein thrombosis (DVT) and can affect quality of life (QoL). ...OBJECTIVES: To compare the prevalence of PTS after acute DVT and the long-term QoL following DVT between patients treated …
BACKGROUND: Postthrombotic syndrome (PTS) is a long-term complication after deep vein thrombosis (DVT) and can affect quality of life …
Clinical Presentation and Short- and Long-term Outcomes in Patients With Isolated Distal Deep Vein Thrombosis vs Proximal Deep Vein Thrombosis in the RIETE Registry.
Bikdeli B, Caraballo C, Trujillo-Santos J, Galanaud JP, di Micco P, Rosa V, Cusidó GV, Schellong S, Mellado M, Del Valle Morales M, Gavín-Sebastián O, Mazzolai L, Krumholz HM, Monreal M; RIETE Investigators. Bikdeli B, et al. JAMA Cardiol. 2022 Aug 1;7(8):857-865. doi: 10.1001/jamacardio.2022.1988. JAMA Cardiol. 2022. PMID: 35830171 Free PMC article.
IMPORTANCE: Insufficient data exist about the clinical presentation, short-term, and long-term outcomes of patients with isolated distal deep vein thrombosis (IDDVT), that is, thrombosis in infrapopliteal veins without proximal extension or pulmonary embolism (PE). …
IMPORTANCE: Insufficient data exist about the clinical presentation, short-term, and long-term outcomes of patients with isola …
Enoxaparin versus dalteparin or tinzaparin in patients with cancer and venous thromboembolism: The RIETECAT study.
Trujillo-Santos J, Farge-Bancel D, Pedrajas JM, Gómez-Cuervo C, Ballaz A, Braester A, Mahé I, Villalobos A, Porras JA, Monreal M; RIETE Investigators. Trujillo-Santos J, et al. Res Pract Thromb Haemost. 2022 Jun 3;6(4):e12736. doi: 10.1002/rth2.12736. eCollection 2022 May. Res Pract Thromb Haemost. 2022. PMID: 35664535 Free PMC article.
OBJECTIVES: The objective of the RIETECAT study was to compare the long-term effectiveness and safety of enoxaparin versus dalteparin or tinzaparin for the secondary prevention of VTE in adults with active cancer. ...
OBJECTIVES: The objective of the RIETECAT study was to compare the long-term effectiveness and safety of enoxaparin versus dalteparin …
Development of Self-Efficacy Tools for Parents and Professionals Caring for Children and Young People with Lymphedema (ILF Parent SE and ILF Professional SE).
Moffatt CJ, Aubeeluck A, Stasi E, Bartoletti R, Roccatello D, Mac Sweeney M, Lapointe C, Pourquier H, Murray S, Mestre S, Quéré I. Moffatt CJ, et al. Among authors: quere i. Lymphat Res Biol. 2021 Oct;19(5):460-467. doi: 10.1089/lrb.2021.0059. Lymphat Res Biol. 2021. PMID: 34672789 Free article.
Background: Self-management is a key aspect of lymphedema treatment and self-efficacy is a key factor linked to long-term adherence to treatment. The study aimed to generate self-efficacy scales to support the care of children and adolescents with lymphedema to support sel …
Background: Self-management is a key aspect of lymphedema treatment and self-efficacy is a key factor linked to long-term adherence t …
Quality of life in patients with pulmonary embolism treated with edoxaban versus warfarin.
Bavalia R, Bistervels IM, Boersma WG, Quere I, Brisot D, Falvo N, Stephan D, Couturaud F, Schellong S, Beyer-Westendorf J, Montaclair K, Ghanima W, Ten Wolde M, Coppens M, Ferrari E, Sanchez O, Carroll P, Roy PM, Kahn SR, Meijer K, Birocchi S, Kovacs MJ, Hugman A, Ten Cate H, Wik H, Pernod G, Sevestre-Pietri MA, Grosso MA, Shi M, Lin Y, Hutten BA, Verhamme P, Middeldorp S; Hokusai post‐PE study investigators. Bavalia R, et al. Among authors: quere i. Res Pract Thromb Haemost. 2021 Jul 14;5(5):e12566. doi: 10.1002/rth2.12566. eCollection 2021 Jul. Res Pract Thromb Haemost. 2021. PMID: 34278193 Free PMC article.
BACKGROUND: Long-term sequelae of acute pulmonary embolism (PE) include decreased quality of life (QoL). ...CONCLUSION: Our findings indicate that patients with an index PE treated with edoxaban or warfarin have a similar long-term QoL. Since our study was a follow- …
BACKGROUND: Long-term sequelae of acute pulmonary embolism (PE) include decreased quality of life (QoL). ...CONCLUSION: Our findings …
Post-thrombotic syndrome.
Visonà A, Quere I, Mazzolai L, Amitrano M, Lugli M, Madaric J, Prandoni P; European Society of Vascular Medicine (ESVM). Visonà A, et al. Among authors: quere i. Vasa. 2021 Sep;50(5):331-340. doi: 10.1024/0301-1526/a000946. Epub 2021 Mar 15. Vasa. 2021. PMID: 33720757
Post-thrombotic syndrome (PTS) is a chronic venous insufficiency manifestation following an episode of deep-vein thrombosis (DVT). It is an important and frequent long-term adverse event of proximal DVT affecting 20-50% of patients. ...
Post-thrombotic syndrome (PTS) is a chronic venous insufficiency manifestation following an episode of deep-vein thrombosis (DVT). It is an …
Primary lymphedema French National Diagnosis and Care Protocol (PNDS; Protocole National de Diagnostic et de Soins).
Vignes S, Albuisson J, Champion L, Constans J, Tauveron V, Malloizel J, Quéré I, Simon L, Arrault M, Trévidic P, Azria P, Maruani A; French National Referral Center for Primary Lymphedema. Vignes S, et al. Among authors: quere i. Orphanet J Rare Dis. 2021 Jan 6;16(1):18. doi: 10.1186/s13023-020-01652-w. Orphanet J Rare Dis. 2021. PMID: 33407666 Free PMC article.
Treatment aims to prevent those complications, reduce the volume with low-stretch bandages, then stabilize it over the long term by exercises and wearing a compression garment. Patient education (or parents of a child) is essential to improve observance....
Treatment aims to prevent those complications, reduce the volume with low-stretch bandages, then stabilize it over the long term by e …
Epidemiology and 3-year outcomes of combined oral contraceptive-associated distal deep vein thrombosis.
Galanaud JP, Sevestre MA, Pernod G, Genty C, Richaud C, Rolland C, Weber L, Kahn SR, Quéré I, Bosson JL; OPTIMEV‐SFMV Investigators. Galanaud JP, et al. Among authors: quere i. Res Pract Thromb Haemost. 2020 Sep 15;4(7):1216-1223. doi: 10.1002/rth2.12409. eCollection 2020 Oct. Res Pract Thromb Haemost. 2020. PMID: 33134787 Free PMC article.
In women of childbearing age, a frequent triggering risk factor is the use of combined oral contraceptive (COC) pills. However, data on the epidemiology and long-term outcomes of COC-associated distal DVT are lacking. OBJECTIVES: To assess the epidemiology and long-term …
In women of childbearing age, a frequent triggering risk factor is the use of combined oral contraceptive (COC) pills. However, data on the …
Long-term risk of postthrombotic syndrome after symptomatic distal deep vein thrombosis: The CACTUS-PTS study.
Galanaud JP, Righini M, Le Collen L, Douillard A, Robert-Ebadi H, Pontal D, Morrison D, Barrellier MT, Diard A, Guénnéguez H, Brisot D, Faïsse P, Accassat S, Martin M, Delluc A, Solymoss S, Kassis J, Carrier M, Quéré I, Kahn SR. Galanaud JP, et al. Among authors: quere i. J Thromb Haemost. 2020 Apr;18(4):857-864. doi: 10.1111/jth.14728. Epub 2020 Feb 11. J Thromb Haemost. 2020. PMID: 31899848 Free article. Clinical Trial.
The risk of developing PTS after isolated distal DVT (infra-popliteal DVT without pulmonary embolism), and the impact of anticoagulant treatment on this risk, are uncertain. METHODS: Long-term follow-up of CACTUS double-blind trial comparing 6 weeks of s.c. nadroparin (171 …
The risk of developing PTS after isolated distal DVT (infra-popliteal DVT without pulmonary embolism), and the impact of anticoagulant treat …
Topical sirolimus 0.1% for treating cutaneous microcystic lymphatic malformations in children and adults (TOPICAL): protocol for a multicenter phase 2, within-person, randomized, double-blind, vehicle-controlled clinical trial.
Leducq S, Caille A, Barbarot S, Bénéton N, Bessis D, Boccara O, Bursztejn AC, Chiaverini C, Dompmartin A, Droitcourt C, Gissot V, Goga D, Guibaud L, Herbreteau D, Le Touze A, Léauté-Labrèze C, Lorette G, Mallet S, Martin L, Mazereeuw-Hautier J, Phan A, Plantin P, Quéré I, Vabres P, Bourgoin H, Giraudeau B, Maruani A; Groupe de Recherche de la Société Française de Dermatologie Pédiatrique. Leducq S, et al. Among authors: quere i. Trials. 2019 Dec 17;20(1):739. doi: 10.1186/s13063-019-3767-8. Trials. 2019. PMID: 31847908 Free PMC article.
Patients will be seen at week 20 (treatment will be stopped) and at month 12 to evaluate long-term efficacy. The primary outcome will be improvement of the CMLM in the area treated with topical sirolimus compared to the area treated with topical vehicle by the investigator …
Patients will be seen at week 20 (treatment will be stopped) and at month 12 to evaluate long-term efficacy. The primary outcome will …
34 results